News on clinical chemistry systems and applications.
The viral assay, developed with Sentinel Diagnostics, improves the ability to monitor viral loads in critical organ transplant populations for the clinical management of infection.
Enzyre is developing a near-patient platform called Enzypad to measure biomarkers in body fluids. The first application will be the monitoring of hemophilia.
The autoimmune diagnostics firm attributed the decline to lower testing volumes amid the SARS-CoV-2 pandemic and a decrease in average reimbursement per test.
Eurobio said the deal fits with its development strategy and brings it into closer proximity to the largest European markets for diagnostic and research products.
The test leverages a novel cancer biomarker that may improve the accuracy and sensitivity of noninvasive bladder cancer testing.
